参考文献
[1] PeterAttia. The straight dope on cholesterol. http://eatingacademy.com/nutriti ... -cholesterol-part-i April 2012.
[2] Sachdeva,A., Cannon, C.P., Deedwania, P.C., Labresh, K.A., Smith, S.C. Jr, Dai, D.,Hernandez, A., Fonarow, G.C. (2009). Lipid levels in patients hospitalized withcoronary artery disease: an analysis of 136,905 hospitalizations in Get WithThe Guidelines. Am Heart J., 157(1):111-117.
[3] Petursson,H., Sigurdsson, J., Bengtsson, C., Nilsen, T., Getz, L. (2012). Is the use ofcholesterol in mortality risk algorithms in clinical guidelines valid? Tenyears prospective data from the Norwegian HUNT 2 study. J. Eval Clin Pract. 18(1): 159–168.
[4] MarkSisson. (2012). The Primal Blueprint. Primal Nutrition, Inc. p. 81-87.
[5] Liang,C.P., Han, S., Senokuchi, T., Tall, A. (2007). The microphages at thecrossroads of insulin resistance and atherosclerosis. Circulation Research. 100: 1546-1555.
[6] JimmyMoore. (2013). Cholesterol Clarity. Victory Belt Publishing Inc.
[7] Cederberg,H., Stancakova, A., Yaluri, N., Modi, S., Kuusisto, J., Laakso, M. Increasedrisk of diabetes with statin treatment is associated with impaired insulinsensitivity and insulin secretion: a 6 year follow-up study of the METSIMcohort. Diabetologia. Mar 10th, 2015.
[8] Okuyama,H., Langsjoen, P., Hamazaki, T., Ogushi, Y., Hama, R., Kobayashi, T., Uchino,H. (2015). Statins stimulate atherosclerosis and heart failure: pharmacologicalmechanisms. Expert Rev. Clin. Pharmacol.8(2): 189-199.